Julia Wattacheril

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension

Naga Chalasani, Manal F. Abdelmalek, Guadalupe García–Tsao et al. · Gastroenterology · 2019 · 326 citations · Full text

Hepatic TLR4 signaling in obese NAFLD

Torfay Sharifnia, Joseph Antoun, Thomas G. Verriere et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2015 · 237 citations · Full text

Immunology, Pathology, Fatty Liver Disease +22

Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study

Samer Gawrieh, Lara Dakhoul, Ethan Miller et al. · Alimentary Pharmacology & Therapeutics · 2019 · 130 citations

Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis

Mohammad Shadab Siddiqui, Mark L. Van Natta, Margery A. Connelly et al. · Journal of Hepatology · 2019 · 128 citations · Full text